Product Code: ETC095027 | Publication Date: Jul 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
Ampicillin is a type of antibiotic that belongs to the penicillin group of drugs. It is used to treat infections caused by certain types of bacteria, including bronchitis, pneumonia, salmonella, and E. coli. Ampicillin has been used commonly in Indonesia for decades as an effective treatment for bacterial infections such as urinary tract infection (UTI).
According to recent trends reported in 6Wresearch report on Indonesia drug sales data from January 2024-April 2025 show that ampicillin was among the top 10 antibiotics prescribed each month during the period with increasing usage towards April 2025. Furthermore, an increase in awareness about preventive healthcare has also increased demand for ampicillin and other antibiotics due to their efficacy against common illnesses such as colds and flus that require prompt treatment with medications like ampicillin.
The primary drivers behind the growth of ampicillin?s market share are mainly related to its wide range of applications in treating various types of bacterial infections such as UTIs; ear, throat and lung infections; skin rashes; sepsis; meningitis; typhoid fever; gonorrhea etc., coupled with its comparatively lower cost than many other antibiotics available on the market today. In addition to this, easy availability through various retail outlets throughout Indonesia has played a major role in driving up demand for this medication over recent years. Moreover government initiatives encouraging people belonging to rural areas or having limited accesses to health care services across Indonesia have also contributed significantly towards making these medicines more accessible especially amongst low income groups thereby leading enhancement in overall sale volume figures across drug stores nation-wide.
The spread of novel coronavirus disease (COVID-19) since early 2025 had led governments worldwide including Government Of Indonesia impose lockdowns which affected operations & businesses countrywide thus impacting production & supply chains while impeding accessibilities thereby adversely affecting both manufacturers & retailers alike nationwide. This unforeseen pandemic situation subsequently impacted global pharmaceutical industry alongwith local markets within indonesia where sales dropped off sharply due decreasing demands from consumers who couldn`t avail medical services physically due imposed restrictions. Consequently this resulted into reduced uptake levels, however not all segments were completely immune instead some categories witnessed surge during above mentioned period example anti - viral, germicidal products etc.. but still there will be considerable degree impact when we look at it holistically.
Some of the major challenges faced by players operating in Indonesia ampicillin market include stringent regulations for drug approvals, lack of qualified personnel, high cost of production and inadequate research & development activities. In addition, rising competition from generic drugs is also hindering the revenue growth potential of this industry.
Major players operating in Indonesia ampicillin market include PT Kimia Farma Tbk., Garuda Pharmasia Inc., PT Kalbe Farma Tbk., PT Darya Varia Laboratoria Tbk., Sanbe Farma Laboratories Ltd., and Merck Sharp & Dohme Corporation (MSD).
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Ampicillin Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Ampicillin Market Revenues & Volume, 2021 & 2031F |
3.3 Indonesia Ampicillin Market - Industry Life Cycle |
3.4 Indonesia Ampicillin Market - Porter's Five Forces |
3.5 Indonesia Ampicillin Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Indonesia Ampicillin Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Indonesia Ampicillin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Indonesia Ampicillin Market Trends |
6 Indonesia Ampicillin Market, By Types |
6.1 Indonesia Ampicillin Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Ampicillin Market Revenues & Volume, By Product, 2018 - 2031F |
6.1.3 Indonesia Ampicillin Market Revenues & Volume, By Ampicillin Capsules, 2018 - 2031F |
6.1.4 Indonesia Ampicillin Market Revenues & Volume, By Ampicillin Sodium, 2018 - 2031F |
6.1.5 Indonesia Ampicillin Market Revenues & Volume, By Ampicillin Granules, 2018 - 2031F |
6.1.6 Indonesia Ampicillin Market Revenues & Volume, By Ampicillin Tablets, 2018 - 2031F |
6.1.7 Indonesia Ampicillin Market Revenues & Volume, By Others, 2018 - 2031F |
6.2 Indonesia Ampicillin Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Ampicillin Market Revenues & Volume, By Adults, 2018 - 2031F |
6.2.3 Indonesia Ampicillin Market Revenues & Volume, By Kids, 2018 - 2031F |
6.2.4 Indonesia Ampicillin Market Revenues & Volume, By Others, 2018 - 2031F |
7 Indonesia Ampicillin Market Import-Export Trade Statistics |
7.1 Indonesia Ampicillin Market Export to Major Countries |
7.2 Indonesia Ampicillin Market Imports from Major Countries |
8 Indonesia Ampicillin Market Key Performance Indicators |
9 Indonesia Ampicillin Market - Opportunity Assessment |
9.1 Indonesia Ampicillin Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Indonesia Ampicillin Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Indonesia Ampicillin Market - Competitive Landscape |
10.1 Indonesia Ampicillin Market Revenue Share, By Companies, 2024 |
10.2 Indonesia Ampicillin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |